Skip to main content
AAN.com
Articles
January 14, 2013

Pathophysiology of spasticity in stroke

January 15, 2013 issue
80 (3_supplement_2) S20-S26

Abstract

Spasticity is defined clinically by increased muscle tone and tendon jerk hyperreflexia in patients who are at rest. However, the excitability of spinal circuits changes during movement, and this definition provides no insight into the extent to which spasticity and associated motor disturbances cause disability. Only a few spinal circuits have been shown to underlie the abnormalities of patients at rest. Movement can be restrained by pathologically enhanced muscle tone, and there is defective control of the feedback to active motoneurons through virtually all spinal reflex pathways. Spasticity does not necessarily require treatment: in fact, some patients rely on the increased muscle tone to help support otherwise weak muscle contractions for stance and locomotion. In addition, much of the increase in muscle tone arises from changes in muscle and motor units, independent of reflex mechanisms. Managing a patient with impairment after a stroke requires therapy tailored to that particular patient because the mechanisms contributing to the disability experienced by one patient may differ from those affecting another.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Ada L, Vattanasilp W, O’Dwyer NJ, Crosbie J. Does spasticity contribute to walking dysfunction after stroke? J Neurol Neurosurg Psychiatry 1998;64:628–635.
2.
Dietz V. Spastic movement disorder: what is the impact of research on clinical practice? J Neurol Neurosurg Psychiatry 2003;74:820–821.
3.
Dietz V, Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 2007;6:725–733.
4.
O‘Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain 1996;119:1737–1749.
5.
O‘Dwyer NJ, Ada L. Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia. Curr Opin Neurol 1996;9:451–455.
6.
McLellan DL. Co-contraction and stretch reflexes in spasticity during treatment with baclofen. J Neurol Neurosurg Psychiatry 1977;40:30–38.
7.
Thilmann AF, Fellows SJ, Garms E. The mechanism of spastic muscle hypertonus: variation in reflex gain over the time course of spasticity. Brain 1991;114:233–244.
8.
Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology 1980;30:1303–1313.
9.
Landau WM. Editorial: spasticity—the fable of a neurological demon and the emperor’s new therapy. Arch Neurol 1974;31:217–219.
10.
Landau WM. Spasticity after stroke: why bother? Stroke 2004;35:1787–1788.
11.
Young RR, Delwaide PJ. Drug therapy: spasticity (first of two parts). N Engl J Med 1981;304:28–33.
12.
Burke D. Spasticity as an adaptation to pyramidal tract injury. Adv Neurol 1988;47:401–423.
13.
Heckman CJ, Johnson M, Mottram C, Schuster J. Persistent inward currents in spinal motoneurons and their influence on human motoneuron firing patterns. Neuroscientist 2008;14:264–275.
14.
Heckman CJ, Mottram C, Quinlan K, Theiss R, Schuster J. Motoneuron excitability: the importance of neuromodulatory inputs. Clin Neurophysiol 2009;120:2040–2054.
15.
Lawrence DG, Kuypers HG. The functional organization of the motor system in the monkey. I. The effects of bilateral pyramidal lesions. Brain 1968;91:1–14.
16.
Pierrot-Deseilligny E, Burke D. The Circuitry of the Human Spinal Cord: Its Role in Motor Control and Movement Disorders. New York: Cambridge University Press; 2005.
17.
Yanagisawa N, Tanaka R, Ito Z. Reciprocal Ia inhibition in spastic hemiplegia of man. Brain 1976;99:555–574.
18.
Alstermark B, Isa T, Pettersson LG, Sasaki S. The C3-C4 propriospinal system in the cat and monkey: a spinal pre-motoneuronal centre for voluntary motor control. Acta Physiol (Oxf) 2007;189:123–140.
19.
Mazevet D, Meunier S, Pradat-Diehl P, Marchand-Pauvert V, Pierrot-Deseilligny E. Changes in propriospinally mediated excitation of upper limb motoneurons in stroke patients. Brain 2003;126:988–1000.
20.
Lance JW. Symposium synopsis. In:, Feldman RG, Young RR, Koella WP, editors. Spasticity: Disordered Motor Control. Miami: Year Book Medical Publishers; 1980:485–494.
21.
Malhotra S, Pandyan AD, Day CR, Jones PW, Hermens H. Spasticity, an impairment that is poorly defined and poorly measured. Clin Rehabil 2009;23:651–658.
22.
Förster O. Resection of the posterior nerve roots of spinal cord. Lancet 1911;178:76–79.
23.
Rushworth G. Spasticity and rigidity: an experimental study and review. J Neurol Neurosurg Psychiatry 1960;23:99–118.
24.
Denny-Brown D. The Cerebral Control of Movement. Springfield: Thomas; 1966:124–143.
25.
Hagbarth KE, Wallin G, Löfstedt L. Muscle spindle responses to stretch in normal and spastic subjects. Scand J Rehabil Med 1973;5:156–159.
26.
Wilson LR, Gandevia SC, Inglis JT, Gracies J, Burke D. Muscle spindle activity in the affected upper limb after a unilateral stroke. Brain 1999;122:2079–2088.
27.
Delwaide PJ. Human monosynaptic reflexes and presynaptic inhibition: an interpretation of spastic hyperreflexia. In:, Desmedt JE, editor. New Developments in Electromyography and Clinical Neurophysiology. Basel, Switzerland: S. Karger AG; 2011:508–522.
28.
Young RR, Delwaide PJ. Drug therapy: spasticity (second of two parts). N Engl J Med 1981;304:96–99.
29.
Faist M, Mazevet D, Dietz V, Pierrot-Deseilligny E. A quantitative assessment of presynaptic inhibition of Ia afferents in spastics: differences in hemiplegics and paraplegics. Brain 1994;117:1449–1455.
30.
Lamy JC, Wargon I, Mazevet D, Ghanim Z, Pradat-Diehl P, Katz R. Impaired efficacy of spinal presynaptic mechanisms in spastic stroke patients. Brain 2009;132:734–748.
31.
Aymard C, Katz R, Lafitte C, et al. Presynaptic inhibition and homosynaptic depression: a comparison between lower and upper limbs in normal human subjects and patients with hemiplegia. Brain 2000;123:1688–1702.
32.
Grey MJ, Klinge K, Crone C, et al. Post-activation depression of soleus stretch reflexes in healthy and spastic humans. Exp Brain Res 2008;185:189–197.
33.
Meunier S, Kwon J, Russmann H, Ravindran S, Mazzocchio R, Cohen L. Spinal use-dependent plasticity of synaptic transmission in humans after a single cycling session. J Physiol 2007;579:375–388.
34.
Katz R, Pierrot-Deseilligny E. Recurrent inhibition of alpha-motoneurons in patients with upper motor neuron lesions. Brain 1982;105:103–124.
35.
Mazzocchio R, Rossi A. Recurrent inhibition in human spinal spasticity. Ital J Neurol Sci 1989;10:337–347.
36.
Okuma Y, Lee RG. Reciprocal inhibition in hemiplegia: correlation with clinical features and recovery. Can J Neurol Sci 1996;23:15–23.
37.
Crone C, Johnsen LL, Biering-Sørensen F, Nielsen JB. Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury. Brain 2003;126:495–507.
38.
Delwaide PJ, Oliver E. Short-latency autogenic inhibition (IB inhibition) in human spasticity. J Neurol Neurosurg Psychiatry 1988;51:1546–1550.
39.
Marque P, Simonetta-Moreau M, Maupas E, Roques CF. Facilitation of transmission in heteronymous group II pathways in spastic hemiplegic patients. J Neurol Neurosurg Psychiatry 2001;70:36–42.
40.
Maupas E, Marque P, Roques CF, Simonetta-Moreau M. Modulation of the transmission in group II heteronymous pathways by tizanidine in spastic hemiplegic patients. J Neurol Neurosurg Psychiatry 2004;75:130–135.
41.
Nardone A, Schieppati M. Reflex contribution of spindle group Ia and II afferent input to leg muscle spasticity as revealed by tendon vibration in hemiparesis. Clin Neurophysiol 2005;116:1370–1381.
42.
Achache V, Mazevet D, Iglesias C, et al. Enhanced spinal excitation from ankle flexors to knee extensors during walking in stroke patients. Clin Neurophysiol 2010;121:930–938.
43.
Lance JW, DeGail P. Spread of phasic muscle reflexes in normal and spastic subjects. J Neurol Neurosurg Psychiatry 1965;28:328–334.
44.
Lewis GN, McNair PJ. Heteronymous Ia-afferent connections in the upper limb following stroke. Muscle Nerve 2010;41:71–77.
45.
Murray KC, Nakae A, Stephens MJ, et al. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat Med 2010;16:694–700.
46.
Gorassini MA, Knash ME, Harvey PJ, Bennett DJ, Yang JF. Role of motoneurons in the generation of muscle spasms after spinal cord injury. Brain 2004;127:2247–2258.
47.
Nickolls P, Collins DF, Gorman RB, Burke D, Gandevia SC. Forces consistent with plateau-like behaviour of spinal neurons evoked in patients with spinal cord injuries. Brain 2004;127:660–670.
48.
McPherson JG, Ellis MD, Heckman CJ, Dewald JP. Evidence for increased activation of persistent inward currents in individuals with chronic hemiparetic stroke. J Neurophysiol 2008;100:3236–3243.
49.
Mottram CJ, Suresh NL, Heckman CJ, Gorassini MA, Rymer WZ. Origins of abnormal excitability in biceps brachii motoneurons of spastic-paretic stroke survivors. J Neurophysiol 2009;102:2026–2038.
50.
Mottram CJ, Wallace CL, Chikando CN, Rymer WZ. Origins of spontaneous firing of motor units in the spastic-paretic biceps brachii muscle of stroke survivors. J Neurophysiol 2010;104:3168–3179.
51.
Gracies JM. Pathophysiology of spastic paresis. I: paresis and soft tissue changes. Muscle Nerve 2005;31:535–551.
52.
Lorentzen J, Grey MJ, Crone C, Mazevet D, Biering-Sørensen F, Nielsen JB. Distinguishing active from passive components of ankle plantar flexor stiffness in stroke, spinal cord injury and multiple sclerosis. Clin Neurophysiol 2010;121:1939–1951.
53.
Vattanasilp W, Ada L, Crosbie J. Contribution of thixotropy, spasticity, and contracture to ankle stiffness after stroke. J Neurol Neurosurg Psychiatry 2000;69:34–39.

Information & Authors

Information

Published In

Neurology®
Volume 80Number 3_supplement_2January 15, 2013
Pages: S20-S26

Publication History

Published online: January 14, 2013
Published in print: January 15, 2013

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

David Burke, MD, DSc
From the Department of Neurology (D.B.), Royal Prince Alfred Hospital and University of Sydney, Australia; Neurorehabilitation Hospital (J.W.), Klinkiken Beelitz GmbH, Clinical Department of Neurological Rehabilitation, Beelitz-Heilstaetten, Germany; and Florey Neuroscience Institutes (G.A.D.), University of Melbourne, Carlton South, Victoria, Australia.
Jörg Wissel, MD, FRCP
From the Department of Neurology (D.B.), Royal Prince Alfred Hospital and University of Sydney, Australia; Neurorehabilitation Hospital (J.W.), Klinkiken Beelitz GmbH, Clinical Department of Neurological Rehabilitation, Beelitz-Heilstaetten, Germany; and Florey Neuroscience Institutes (G.A.D.), University of Melbourne, Carlton South, Victoria, Australia.
Geoffrey A. Donnan, MD
From the Department of Neurology (D.B.), Royal Prince Alfred Hospital and University of Sydney, Australia; Neurorehabilitation Hospital (J.W.), Klinkiken Beelitz GmbH, Clinical Department of Neurological Rehabilitation, Beelitz-Heilstaetten, Germany; and Florey Neuroscience Institutes (G.A.D.), University of Melbourne, Carlton South, Victoria, Australia.

Notes

Correspondence to Dr. Burke: [email protected]
Author disclosures are provided at the end of the article.
This Neurology® supplement was not peer-reviewed. Information contained in this Neurology® supplement represents the opinions of the authors. These opinions are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology®.

Disclosure

Dr. Burke serves as editor-in-chief for Clinical Neurophysiology and as an editorial board member of The Journal of Clinical Neuroscience. He serves and has served in the past as chief investigator for research funded by NHMRC Project Grants, and has also received funding from the Sydney Foundation for Medical Research, the Philip Bushell Foundation, and the Brain Foundation. Dr. Wissel served on scientific advisory boards for and received speaker honoraria, funding for travel, and research support from Allergan, Inc., Merz Pharmaceuticals, Medtronic, and Ipsen Pharma. Dr. Donnan served on scientific advisory boards for and received speaker honoraria and funding for travel from Allergan, Boehringer Ingelheim, Bayer, and Sanofi. He also served as a journal editor/associate editor/editorial board member of Lancet Neurology, Stroke, Cerebrovascular Diseases, and the International Journal of Stroke.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. I Feel! Therefore, I Am from Pain to Consciousness in DOC Patients, International Journal of Molecular Sciences, 24, 14, (11825), (2023).https://doi.org/10.3390/ijms241411825
    Crossref
  2. Botulinum Toxin and Dynamic Splint Restore Grasping Function after Stroke: A Case Report, International Journal of Environmental Research and Public Health, 20, 6, (4873), (2023).https://doi.org/10.3390/ijerph20064873
    Crossref
  3. The Place of Botulinum Toxin in Spastic Hemiplegic Shoulder Pain after Stroke: A Scoping Review, International Journal of Environmental Research and Public Health, 20, 4, (2797), (2023).https://doi.org/10.3390/ijerph20042797
    Crossref
  4. An online method to monitor hand muscle tone during robot-assisted rehabilitation, Frontiers in Robotics and AI, 10, (2023).https://doi.org/10.3389/frobt.2023.1093124
    Crossref
  5. New insights into acupuncture techniques for poststroke spasticity, Frontiers in Public Health, 11, (2023).https://doi.org/10.3389/fpubh.2023.1155372
    Crossref
  6. MCP extensors respond faster than flexors in individuals with severe-to-moderate stroke-caused impairment: Evidence of uncoupled neural pathways, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1119761
    Crossref
  7. Shear wave ultrasound elastography of the biceps brachii can be used as a precise proxy for passive elbow torque in individuals with hemiparetic stroke, Physiological Reports, 11, 10, (2023).https://doi.org/10.14814/phy2.15691
    Crossref
  8. A Method for Quantification of Stretch Reflex Excitability During Ballistic Reaching, IEEE Transactions on Neural Systems and Rehabilitation Engineering, 31, (2698-2704), (2023).https://doi.org/10.1109/TNSRE.2023.3283861
    Crossref
  9. Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review, Toxicon, 229, (107150), (2023).https://doi.org/10.1016/j.toxicon.2023.107150
    Crossref
  10. Comparison of the immediate effects of plantar vibration of both feet with the plantar vibration of the affected foot on balance in patients with stroke: Preliminary findings, Journal of Bodywork and Movement Therapies, 36, (45-49), (2023).https://doi.org/10.1016/j.jbmt.2023.06.001
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share